Biosystems Technology Limited
Company profile
DissolvedUnited Kingdom
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2021-12-31
IXBRL · 122 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 122 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 64
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- secr-frs-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0110_09683089_20211231
- Source archive
- Accounts_Monthly_Data-September2022.zip
Accounts to 2020-12-31
IXBRL · 118 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 118 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 60
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0092_09683089_20201231
- Source archive
- Accounts_Monthly_Data-July2021.zip
Accounts to 2019-12-31
IXBRL · 95 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 95 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 41
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0076_09683089_20191231
- Source archive
- Accounts_Monthly_Data-March2020.zip
Accounts to 2018-12-31
IXBRL · 94 source facts · 15 selected values
Not assessedlegacy record
Accounts to 2018-12-31
IXBRL · 94 source facts · 15 selected values
Not assessed
legacy record
- Reporting period
- 2018-01-01 to 2018-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 41
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0063_09683089_20181231
- Source archive
- Accounts_Monthly_Data-February2019.zip
Accounts to 2017-12-31
IXBRL · 88 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2017-12-31
IXBRL · 88 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2017-01-01 to 2017-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 38
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0057_09683089_20171231
- Source archive
- Accounts_Monthly_Data-August2018.zip
Accounts to 2016-12-31
IXBRL · 80 source facts · 9 selected values
Not assessedlegacy record
Accounts to 2016-12-31
IXBRL · 80 source facts · 9 selected values
Not assessed
legacy record
- Reporting period
- 2015-07-13 to 2016-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 26
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0041_09683089_20161231
- Source archive
- Accounts_Monthly_Data-April2017.zip
Registered details
09683089- Status
- Dissolved
- Type
- Unknown
- Incorporated
- —
- Jurisdiction
- —
- Registered office
- —
Classification
0 SIC codesNo SIC classification available.
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsEurostars: Innovative Multifaceted Platform for Antimicrobials Commercialisation Transformation 2Lead
Innovate UK · Feasibility Studies · 2020-06-01 – 2021-03-31
£74,826
awarded
Assessing the relevance of Galleria mellonella to antibiotic drug discovery for pulmonary infectionsNC3Rs · Research Grant · 2019-07-14 – 2020-01-14 · with 1 other participant£72,195whole project
Assessing the relevance of Galleria mellonella to antibiotic drug discovery for pulmonary infections
NC3Rs · Research Grant · 2019-07-14 – 2020-01-14 · with 1 other participant
£72,195
whole project
King'S College LondonleadBiosystems Technology Ltd
Innovative Multifaceted Platform for Antimicrobials Commercialisation Transformation 2Lead
Innovate UK · EU-Funded · 2018-10-01 – 2021-09-30
£192,853
awarded
Innovative Multifaceted Platform for Antimicrobials Commercialisation Transformation 2Lead
EU · EU-Funded · 2018-09-30 – 2021-09-29
£192,853
whole project
Innovative Multifaceted Platform for Antimicrobials Commercialisation Transformation 2
EU · EU-Funded · 2018-09-30 – 2021-09-29
£192,853
whole project
TruLarv – novel drug re-purposing platformLead
Innovate UK · Feasibility Studies · 2018-09-01 – 2019-08-31
£69,799
awarded
TruLarv: innovative, non-mammalian preclinical technology platformLeadInnovate UK · Feasibility Studies · 2017-09-01 – 2018-08-31 · with 1 other participant£49,155awarded
TruLarv: innovative, non-mammalian preclinical technology platformLead
Innovate UK · Feasibility Studies · 2017-09-01 – 2018-08-31 · with 1 other participant
£49,155
awarded
Biosystems Technology Limitedlead£49,155